Effects of NAC on Symptoms of CHR Patients

Recruiting N/A Interventional Study
Prodromal Schizophrenia
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
16 – 35
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
90 (estimated)
Sponsor
Centre for Addiction and Mental Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Schizophrenia is a chronic debilitating psychotic disorder. Identifying persons with "clinical high-risk" (CHR) symptoms, which are like those of schizophrenia but less severe, and providing psychiatric care to these individuals has been shown to help prevent psychosis. Current medications used for CHR symptoms, however, are associated with substantial side effect burden. Therefore, practice guide…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. meeting Criteria of Psychosis-Risk Syndromes (COPS) criteria on the Structured Interview for Psychosis-Risk Syndromes (SIPS) 2. capacity to provide informed consent 3. if female, participant is not of child-bearing potential, defined as females who have undergone a sterilizat…
Contacts

Michael Kiang, MD, PhD

416-535-8501

michael.kiang@camh.ca

CONTACT

Jenny Lepock, PhD

416-535-8501

jenny.lepock@camh.ca

CONTACT